NCT03827616View on ClinicalTrials.gov

Moderately Hypofractionated Radiotherapy for Prostate Cancer.

PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 25, 2019

Primary Completion Date

February 1, 2029

Study Completion Date

February 1, 2030

Conditions
Prostatic NeoplasmsGenital Neoplasms
Interventions
RADIATION

Hypofractionated IMRT using helical Tomotherapy.

70 Gy in 28 fractions intensity-modulated radiotherapy (IMRT)

RADIATION

Hypofractionated IMRT using helical Tomotherapy.

60 Gy in 20 fractions intensity-modulated radiotherapy (IMRT) using helical Tomotherapy.

Trial Locations (1)

420029

Tatarstan Cancer Cente, Kazan'

All Listed Sponsors
lead

Tatarstan Cancer Center

OTHER